Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
14,462 total articles
The mobility spin-off simplified S&P Global’s portfolio and concentrated cash flow in higher-margin, recurring products. That structural change, combined with steady demand for benchmark data and ratings, sets up a tactical long trade aiming to capture a re-rating as investors re-underwrite growth and free cash flow.
Novo Nordisk has been punished for near-term earnings and revenue downgrades, yet the stock trades at a single-digit P/E with a healthy yield and technical support near oversold levels. This trade buys into a re-rating scenario against its higher-growth peer while acknowledging meaningful competitive and execution risks.
ASML is trading above its short-term moving averages, carries strong margin profiles and has upbeat analyst expectations for Q3. With a market cap near $703.5B and near-term catalysts tied to EUV demand for AI chips, the setup looks actionable for a swing trade into post-earnings rotation. Entry, stop and target are provided with a clear time horiz…
Astec Industries (ASTE) fell to a fresh low near $38.34 on 10/07/2026 after a recent run-up earlier this year. The sell-off has created a disciplined buying opportunity: the company shows improving margins, strong adjusted EBITDA momentum, a completed accretive acquisition, and an EV/EBITDA of ~11.9 that leaves upside if management executes. This t…
McDonald's (MCD) is trading near its 52-week low after a pullback that punished growth expectations. The business still generates durable free cash flow ($7.385B trailing FCF) and pays a healthy ~3.2% dividend. For traders willing to accept operational execution risk, a controlled long with a $231 entry, $260 target and $222 stop balances upside fr…
PMV Pharmaceuticals is a small-cap precision oncology company developing rezatapopt, a first-in-class reactivator of the TP53 Y220C mutation. With a 50% overall response rate reported from a 48-patient cohort, an NDA planned for Q1 2027, and a companion diagnostic partnership in place, the stock looks mispriced against the binary upside of regulato…
Oracle looks like a good swing-long after recent stabilization around $140. The business is benefitting from a huge contracted AI backlog, improving cloud revenue dynamics and still-high profitability metrics. Valuation at roughly $435B market cap and a mid-20s P/E leaves room for multiple expansion if execution continues. Trade plan provided with …
Hyundai is shifting strategy to emphasize hybrid models as BEV demand softens. That tactical pivot should protect near-term revenue and margins while maintaining optionality on battery electric vehicle growth. We initiate a long trade with a $8.50 entry, $11.00 target and $7.00 stop, horizon ~180 trading days.
We maintain a Strong Buy on Johnson & Johnson (JNJ). Valuation looks reasonable versus J&J's cash generation and defensive healthcare moat, and upcoming pipeline shots - notably SPY072 and potential IBD combination data in Q4 2026 - create asymmetric upside. Pair that with a 2.07% yield, $22.2B in free cash flow and a manageable balance sheet and t…
Rocket Lab's pending $8B acquisition of Iridium is the catalyst that could push the company from growth mode into meaningful profitability. Balance sheet strength and low debt make the deal plausible, but a GAO protest and integration execution create a binary outcome. We lay out an actionable trade with entry, stop and target, and why this is a mi…
Climb Global Solutions (CLMB) delivered a standout 2025 with 40% revenue growth and a clean balance sheet. The market is giving the company a premium multiple, but accelerating cloud and cybersecurity distribution, a recent EU tuck-in, and improving free cash flow make a controlled long trade attractive. This idea lays out an entry at $33.00, a sto…
Magna is showing sequential profit improvement, returning capital to shareholders and winning software-driven ADAS programs. The stock trades below prior highs on a reasonable EV/EBITDA and a mid-teens implied upside to the 52-week high. We recommend a position trade sized for medium risk with precise entry, stop and target.
United Internet (UTDI) trades at a persistent discount to its private-asset value. Operational stabilization at its core broadband business, an active capital-allocation pivot and a clearer path to monetizing minority stakes make it likely that the discount will shrink. This trade plan targets a gap-narrowing move over the next 180 trading days wit…
SL Green's recent leasing cadence and strategic asset moves — plus a yield near 5% and a below-par book multiple — give the stock asymmetric upside versus its current price. This trade idea lays out an actionable long with entry, target and stop, framed against the company's heavy leverage and cash-flow recovery risks.
PagSeguro (PAGS) is trading at a low-single-digit earnings multiple with improving technicals and a clear macro catalyst in Brazil's presidential runoff. This trade idea outlines a mid-term long with concrete entry, stops and targets while weighing the upside drivers and the key risks that could derail the setup.
Brookfield Renewable offers a high-distribution income stream backed by long-term contracted renewable assets. The business is durable and growth-capable, but the market is pricing a structural discount tied to rate, capex and payout concerns. This trade idea: take the yield at an attractive entry, protect capital with a strict stop, and treat any …
Diebold Nixdorf (DBD) trades at reasonable valuation metrics (EV/EBITDA ~7.8, P/E ~20) and generates meaningful free cash flow. The trade idea is a conditional long: buy on the expectation management will accelerate converting equipment and services backlog into cash and margin expansion. If that conversion stalls or macro-driven capex cuts hit ban…
Reddit has quietly re-accelerated user engagement and is expanding monetization beyond traditional display ads. For traders willing to accept platform and ad-cycle risk, a structured long trade captures upside from ad recovery, premium subscriptions and emerging commerce initiatives over the next 180 trading days.
We upgrade FLTR to a Buy and add to exposure at $25.52. The ETF yields roughly 4.3% (30-day SEC yield 4.24%) and sits near a psychologically low-volatility price range; technicals show short-term oversold conditions while short interest and heavy short volume create an asymmetric risk/reward for a tactical long position.
GSK at $47.10 offers a risk/reward where accelerating specialty medicines growth, recent bolt-on deals and a 3.8% yield matter more than near-term technical weakness. Enter a mid-term long (45 trading days) with tight risk management: entry $47.10, stop $44.00, target $57.00.
Silgan (SLGN) is a cash-rich, low-multiple packaging business trading near a year-low. At an entry of $32.40 the company's free cash flow yield clears 10%, creating a favorable asymmetric trade: limited downside to a conservative stop and meaningful upside if volumes and margins normalize and the market re-rates. This is a long-term trade (up to 18…
Eli Lilly remains the growth engine of big-cap healthcare thanks to Mounjaro and Zepbound, high margins, and expanding indications. The stock trades at a premium, but with consensus 2026 revenue approaching $89B and EPS growth still accelerating, a structured long into 10/29/2026 earnings with a defined stop offers an attractive risk/reward for swi…
Sezzle's recent pullback creates a low-risk entry to play accelerating subscriber growth, improving marketing ROI and expanding enterprise traction. Valuation is demanding on headline multiples, but cash flow generation and robust top-line momentum support a mid-term long trade with defined risk.
Lennar is trading around 0.85x book with a market cap near $18.0B, solid free cash flow, and a large new anchor investor in Berkshire Hathaway. The business is cyclical and earnings are under pressure, but the balance sheet and shareholder-friendly tailwinds create a structured, medium-risk long trade: entry $75.58, stop $67.00, target $95.00 over …
Alphabet trades at roughly 17x earnings with $53B of free cash flow and a fortress-like balance sheet. Short-term macro noise and AI capex headlines create entry points; we outline an actionable swing trade with defined entry, stop and target and explain the fundamental drivers and risks.
